---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-23-000096"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T17:27:01.148575+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Johnson & Johnson EVP MedTech Ashley McEvoy resigns effective October 20, 2023

## Summary
- McEvoy resigned as Executive Vice President, Worldwide Chair MedTech and Executive Committee member.
- Resignation effective October 20, 2023; she will remain through Q1 2024 for transition.
- No replacement or reason for resignation was disclosed in the filing.

## SEC filing metadata
- accession: 0000200406-23-000096
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/0000200406-23-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/jnj-20231020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-23-000096
- JSON: https://secwatch.observer/filing/0000200406-23-000096.json
- Plain text: https://secwatch.observer/filing/0000200406-23-000096.txt

## Key facts
- Executive change
  Ashley McEvoy resigned as Executive Vice President, Worldwide Chair MedTech at JOHNSON & JOHNSON.
  - Action: resigned
  - Role: Executive Vice President, Worldwide Chair MedTech
  source text: Ashley McEvoy resigned from her position as Executive Vice President, Worldwide Chair MedTech and member of the Executive Committee effective October 20, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/0000200406-23-000096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
